Communique from extra general meeting in Senzime AB (publ)
(WorldNews Europe)

Introduction of employee stock option program 2020/2023 The extra general meeting resolved, in accordance with the proposal of the board of directors, to introduce employee stock option program 2020/2023 through a directed issue of warrants to the Company`s wholly owned subsidiary MD Biomedical AB, corp.reg.no 556837-0273 (the `Subsidiary`), in order to ensure the Company`s delivery of shares according to the employee stock option program and to cover cash flow effects from potential social security costs arising from the employee stock option program and to approve transfer of warrants or shares in the Company from the Subsidiary to the participant in the employee stock option program. The...